by Truveta Research | Apr 3, 2025 | Research, Research Insights
Measles vaccination rates for children under 24 months in 2024 remain lower than in 2020. In 2024, the average yearly measles vaccination rate for children by 13 months was 58.9% and 68.5% for children by 15 months. Vaccination patterns for children living in both...
by Truveta staff | Mar 31, 2025 | Research
The overall rate of respiratory virus-associated hospitalizations decreased in February, although influenza continues to be the leading cause of respiratory virus-associated hospitalizations (3.5% of all hospitalizations). Among children aged 0–4 years,...
by Terry Myerson, CEO | Mar 27, 2025 | News
At Truveta, our mission is Saving Lives with Data, and we are thinking about the HHS leadership mission of making American’s healthier, and how to help the talented scientists of HHS do more with less. We’d like to contribute to this important mission – starting...
by Michael Simonov, MD | Mar 26, 2025 | News
Today, we’re excited to celebrate our latest innovation in Truveta across both Truveta Data and Truveta Studio. Truveta Data has expanded to include new administrative data to enable more comprehensive analyses of healthcare outcomes and patient journeys. We...
by Truveta staff | Mar 20, 2025 | Data
Why autoimmune research needs better real-world data Biologics like Humira, Enbrel, and Rinvoq have transformed autoimmune treatment, revolutionizing treatment for patients with chronic inflammatory infections. However, the traditional methods of studying these...
